TRENTAL TAB 400MG DIN 00586625
Health Canada record
| Active ingredient(s) | PENTOXIFYLLINE 400 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C04AD03 PENTOXIFYLLINE |
| Original market date | 31-Dec-1984 |
| Current status date | 29-Aug-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENTOXIFYLLINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02230090 | APO-PENTOXIFYLLINE SR | APOTEX INC | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Marketed |
| 02543087 | JAMP PENTOXIFYLLINE SR | JAMP PHARMA CORPORATION | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Marketed |
| 02181533 | NAVICON | VETOQUINOL N A INC | Powder | PENTOXIFYLLINE 2 G | Cancelled Post Market |
| 01955543 | NAVICON PWR 2G | STERIVET, DIVISION OF VÉTOQUINOL N.-A. INC. | Powder | PENTOXIFYLLINE 2 G | Cancelled Post Market |
| 02230401 | NU-PENTOXIFYLLINE-SR 400 MG | NU-PHARM INC | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 01968432 | RATIO-PENTOXIFYLLINE | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 02221977 | TRENTAL | SANOFI-AVENTIS CANADA INC | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
| 01989685 | TRENTAL SRT 400MG | HOECHST ROUSSEL CANADA INC. | Tablet (Extended-Release) | PENTOXIFYLLINE 400 MG | Cancelled Post Market |
International API supply for PENTOXIFYLLINE
7 valid EDQM Certificates of Suitability from 7 holders. 5 active FDA Drug Master Files.
Request a quote for TRENTAL TAB 400MG